Together, this data suggest that paracrine signaling between cancer cells and the surrounding fibroblasts in tumors with a GOF mutant p53 is partly mediated by enhanced NFκB signaling, and this can stimulate HSPG2 expression and deposition in the ECM (Fig. 6j). Here, HSPG2 is linked to cancer.